2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine

C114H225N27O — CID 158330369

IUPAC2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine
SMILESCCCCN(c1nc(C)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)C1CC(C)(C)N(C)C(C)(C)C1.CNCCCN(C)CCN(C)CCCNC.Cc1nc(N2CCOCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.Cc1nc(NC(C)(C)CC(C)(C)C)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1
InChIInChI=1S/C37H72N8.C33H62N8O.C32H61N7.C12H30N4/c1-27-38-30(41-37(13,14)26-32(2,3)4)40-31(39-27)45(29-24-35(9,10)43-36(11,12)25-29)21-19-17-16-18-20-44(15)28-22-33(5,6)42-34(7,8)23-28;1-25-34-28(40-17-19-42-20-18-40)36-29(35-25)41(27-23-32(6,7)38-33(8,9)24-27)16-14-12-11-13-15-39(10)26-21-30(2,3)37-31(4,5)22-26;1-14-16-18-38(25-20-29(4,5)36(12)30(6,7)21-25)27-33-24(3)34-28(35-27)39(19-17-15-2)26-22-31(8,9)37(13)32(10,11)23-26;1-13-7-5-9-15(3)11-12-16(4)10-6-8-14-2/h28-29,42-43H,16-26H2,1-15H3,(H,38,39,40,41);26-27,37-38H,11-24H2,1-10H3;25-26H,14-23H2,1-13H3;13-14H,5-12H2,1-4H3
InChIKeyGPXUUINWJGAZDR-UHFFFAOYSA-N
MW1990.24 g/mol
LogP19.42
Rot. Bonds45

About 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine

2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine (PubChem CID 158330369) has the molecular formula C114H225N27O and a molecular weight of 1990.24 g/mol. Its IUPAC name is 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine.

Molecular Properties

Compound Name2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine
PubChem CID158330369
Molecular FormulaC114H225N27O
Molecular Weight1990.24 g/mol
Exact Mass1988.84
IUPAC Name2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine
SMILESCCCCN(c1nc(C)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)C1CC(C)(C)N(C)C(C)(C)C1.CNCCCN(C)CCN(C)CCCNC.Cc1nc(N2CCOCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.Cc1nc(NC(C)(C)CC(C)(C)C)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1
InChIInChI=1S/C37H72N8.C33H62N8O.C32H61N7.C12H30N4/c1-27-38-30(41-37(13,14)26-32(2,3)4)40-31(39-27)45(29-24-35(9,10)43-36(11,12)25-29)21-19-17-16-18-20-44(15)28-22-33(5,6)42-34(7,8)23-28;1-25-34-28(40-17-19-42-20-18-40)36-29(35-25)41(27-23-32(6,7)38-33(8,9)24-27)16-14-12-11-13-15-39(10)26-21-30(2,3)37-31(4,5)22-26;1-14-16-18-38(25-20-29(4,5)36(12)30(6,7)21-25)27-33-24(3)34-28(35-27)39(19-17-15-2)26-22-31(8,9)37(13)32(10,11)23-26;1-13-7-5-9-15(3)11-12-16(4)10-6-8-14-2/h28-29,42-43H,16-26H2,1-15H3,(H,38,39,40,41);26-27,37-38H,11-24H2,1-10H3;25-26H,14-23H2,1-13H3;13-14H,5-12H2,1-4H3
InChIKeyGPXUUINWJGAZDR-UHFFFAOYSA-N
XLogP19.42
TPSA245.09 Ų
H-Bond Donors7
H-Bond Acceptors28
Rotatable Bonds45
Heavy Atoms142
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001990.24
LogP ≤ 519.42
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine?
The IUPAC name of 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine (CID 158330369) is 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine.
What is the SMILES notation for 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine?
The canonical SMILES for 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine is CCCCN(c1nc(C)nc(N(CCCC)C2CC(C)(C)N(C)C(C)(C)C2)n1)C1CC(C)(C)N(C)C(C)(C)C1.CNCCCN(C)CCN(C)CCCNC.Cc1nc(N2CCOCC2)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.Cc1nc(NC(C)(C)CC(C)(C)C)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.
What is the InChIKey of 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine?
The InChIKey is GPXUUINWJGAZDR-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H72N8.C33H62N8O.C32H61N7.C12H30N4/c1-27-38-30(41-37(13,14)26-32(2,3)4)40-31(39-27)45(29-24-35(9,10)43-36(11,12)25-29)21-19-17-16-18-20-44(15)28-22-33(5,6)42-34(7,8)23-28;1-25-34-28(40-17-19-42-20-18-40)36-29(35-25)41(27-23-32(6,7)38-33(8,9)24-27)16-14-12-11-13-15-39(10)26-21-30(2,3)37-31(4,5)22-26;1-14-16-18-38(25-20-29(4,5)36(12)30(6,7)21-25)27-33-24(3)34-28(35-27)39(19-17-15-2)26-22-31(8,9)37(13)32(10,11)23-26;1-13-7-5-9-15(3)11-12-16(4)10-6-8-14-2/h28-29,42-43H,16-26H2,1-15H3,(H,38,39,40,41);26-27,37-38H,11-24H2,1-10H3;25-26H,14-23H2,1-13H3;13-14H,5-12H2,1-4H3.
What are the key properties of 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine?
2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine has a molecular weight of 1990.24 g/mol, XLogP of 19.42, 45 rotatable bonds, 7 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 2-N,4-N-dibutyl-6-methyl-2-N,4-N-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;N,N'-dimethyl-N'-[2-[methyl-[3-(methylamino)propyl]amino]ethyl]propane-1,3-diamine;N-methyl-N'-(4-methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)-N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-4-N-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine is sourced from PubChem (CID 158330369), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).